The ELISA gives a detailed profile of Brucella-specific antibodies (IgM, IgG, and IgA) and tends to have a higher sensitivity compared to RBPT, making it highly effective for diagnosing both acute and chronic stages of brucellosis and is well-suited for large-scale screening [87,150]. The gene discussed is CD79A; the disease is brucellosis.